4.6 Article

Molecular Analysis of SARS-CoV-2 Lineages in Armenia

Journal

VIRUSES-BASEL
Volume 14, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/v14051074

Keywords

COVID-19; SARS-CoV-2; coronavirus; nanopore sequencing; Illumina sequencing; whole-genome sequencing; Armenia

Categories

Funding

  1. SeedingLabs Instrumental Access
  2. World Bank
  3. Armenian National Science and Education Fund [NS-molbio-2522]
  4. State Target Program of the Government of the Republic of Armenia [1-8/20TB]

Ask authors/readers for more resources

The sequencing of SARS-CoV-2 in Armenia revealed six clades and their transmission routes, with each clade being responsible for different waves of positive case increase. The study also showed that mutations did not affect PCR testing accuracy and that nanopore sequencing is a viable alternative for large-scale molecular epidemiology research.
The sequencing of SARS-CoV-2 provides essential information on viral evolution, transmission, and epidemiology. In this paper, we performed the whole-genome sequencing of SARS-CoV-2 using nanopore and Illumina sequencing to describe the circulation of the virus lineages in Armenia. The analysis of 145 full genomes identified six clades (19A, 20A, 20B, 20I, 21J, and 21K) and considerable intra-clade PANGO lineage diversity. Phylodynamic and transmission analysis allowed to attribute specific clades as well as infer their importation routes. Thus, the first two waves of positive case increase were caused by the 20B clade, the third peak caused by the 20I (Alpha), while the last two peaks were caused by the 21J (Delta) and 21K (Omicron) variants. The functional analyses of mutations in sequences largely affected epitopes associated with protective HLA loci and did not cause the loss of the signal in PCR tests targeting ORF1ab and N genes as confirmed by RT-PCR. We also compared the performance of nanopore and Illumina short-read sequencing and showed the utility of nanopore sequencing as an efficient and affordable alternative for large-scale molecular epidemiology research. Thus, our paper describes new data on the genomic diversity of SARS-CoV-2 variants in Armenia in the global context of the virus molecular genomic surveillance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available